1 report

  • 4.7. GLP-1 AGONISTS, DPP4 INHIBITORS AND SGLT2 INHIBITORS: KEY
  • 6. APPENDIX 1: TABULATED DATA

DPP## INHIBITORS BLOCK THE ACTIVITY OF GLP-## AND GIP.

  • Antidiabetics
  • Diabetes
  • Gliptins
  • Pharmaceutical
  • Mitsubishi Corporation